Table 1.
Clinical and biochemical characteristics of study subjects
| CAD subjects (n = 102) | Control subjects (n = 104) | p-value | |
| Age (years) | 50.1 ± 5.3 | 47.5 ± 3.7 | <0.02 |
| Sex (M/F) | 96/6 | 89/15 | NS |
| Body Mass Index (kg/m2) | 26.9 ± 3.2 | 26.4 ± 3.7 | NS |
| Smokers (%) | 85.2% | 52.5% | <0.002 |
| Hypertensive (%) | 22.5 | 14.5 | NS |
| Total cholesterol (mg/dl) | 197.3 ± 33.7 | 199.8 ± 41.7 | NS |
| HDL-cholesterol (mg/dl) | 27.6 ± 8.2 | 38.1 ± 10.2 | <0.0001 |
| LDL-cholesterol (mg/dl) | 145.6 ± 36.9 | 119.5 ± 32.9 | <0.0001 |
| Total triglycerides (mg/dl) | 211.3 ± 63.6 | 188.1 ± 97.4 | <0.0006 |
| APO AI (mg/dl) | 107.2 ± 17.5 | 129.1 ± 23.1 | <0.0001 |
| APO B (mg/dl) | 117.7 ± 25.5 | 101.1 ± 24.9 | <0.01 |
| APO AII (mg/dl) | 38.7 ± 6.4 | 43.9 ± 9.0 | <0.001 |
| APO CII (mg/dl) | 4.03 ± 1.4 | 3.99 ± 1.6 | NS |
| APO CIII (mg/dl) | 12.1 ± 2.3 | 13.1 ± 3.2 | <0.008 |
| APO E (mg/dl) | 8.6 ± 2.1 | 10.2 ± 3.3 | <0.0001 |
Data are given as means ± SD. Smokers were those currently smoking at baseline. The statistical analysis of total triglycerides and Lp(a) were performed on log-transformed values, but the untransformed values are given in table. After age-standardisation, continuous variables were compared by t-test and ANOVA, and categorical variables by χ2 test